Tower Research Capital LLC (TRC)
Position in APRE — Aprea Therapeutics, Inc.
CIK 1533421
NEW YORK, NY
Position in APRE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$2,879
-$1,032 QoQ
Shares Held
3,590
-30.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 28 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. APRE ranks #411 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in APRE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,879 | 3,590 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $3,911 | 5,127 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,676 | 7,827 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $837 | 568 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,007 | 2,963 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $6,785 | 3,326 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,862 | 1,478 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,615 | 1,315 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,111 | 2,730 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,532 | 1,126 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,575 | 548 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,279 | 1,747 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,473 | 3,325 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,557 | 1,477 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $12,305 | 47,588 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $14,506 | 22,318 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $35,521 | 47,362 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $62,181 | 33,431 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $63,214 | 22,026 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $18,360 | 3,593 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,582 | 6,472 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $51,284 | 10,056 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $17,982 | 3,655 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $208,551 | 8,668 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $56,308 | 1,452 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||